MAIA Biotechnology, Inc.

NYSE American MAIA

MAIA Biotechnology, Inc. Dividend Yield on January 14, 2025: 0.00%

MAIA Biotechnology, Inc. Dividend Yield is 0.00% on January 14, 2025, a 0.00% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

MAIA Biotechnology, Inc. 52-week high Dividend Yield is 0.00% on January 14, 2025, which is 0.00% below the current Dividend Yield.
MAIA Biotechnology, Inc. 52-week low Dividend Yield is 0.00% on January 14, 2025, which is 0.00% below the current Dividend Yield.
MAIA Biotechnology, Inc. average Dividend Yield for the last 52 weeks is 0.00%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NYSE American: MAIA

MAIA Biotechnology, Inc.

CEO	Dr. Vlad Vitoc M.B.A., M.D.
IPO Date	July 28, 2022
Location	United States
Headquarters	444 West Lake Street
Employees	13
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.

Key trends

Past 5 years